HIV infection among Quebec women giving birth to live infants.

An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory. CMAJ (1990) 2.21

Women and HIV infection and AIDS in Canada: should we worry? CMAJ (1990) 2.19

Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. J Clin Microbiol (1992) 2.10

HIV infection among women undergoing abortion in Montreal. CMAJ (1995) 1.58

Deliveries, abortion and HIV-1 infection in Rome, 1989-1994. The Lazio AIDS Collaborative Group. Eur J Epidemiol (1997) 1.41

Confronting HIV infection in prisons. CMAJ (1994) 1.32

HIV infection among Quebec women giving birth to live infants. CMAJ (1991) 1.12

Prevalence of HIV infection among pregnant women in Newfoundland. CMAJ (1996) 1.10

Combining pooling and alternative algorithms in seroprevalence studies. J Clin Microbiol (1993) 0.95

HIV infection among Quebec women giving birth to live infants. CMAJ (1991) 0.94

Do physicians discuss HIV testing during prenatal care? Can Fam Physician (1997) 0.94

Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group. CMAJ (1994) 0.87

Periodic health examination, 1992 update: 3. HIV antibody screening. Canadian Task Force on the Periodic Health Examination. CMAJ (1992) 0.78

Changing epidemiology of AIDS. Can Fam Physician (1994) 0.75

Outpatient Management of HIV Infection: Providing adequate care to HIV patients. Can Fam Physician (1992) 0.75

AIDS, memory and the history of medicine: musings on the Canadian response. Genitourin Med (1994) 0.75

[Not Available]. Can Fam Physician (1991) 0.75

Human immunodeficiency virus as a sexually transmitted disease: Manitoba's HIV unlinked seroprevalence study. Can J Infect Dis (1992) 0.75

Heterosexual transmission of human immunodeficiency virus infection - Strategies for prevention. Can J Infect Dis (1991) 0.75

Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA (1988) 6.14

Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med (1988) 6.00

Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program. Public Health Rep (1988) 5.88

Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Engl J Med (1987) 2.81

Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42

Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41

Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28

HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data. Public Health Rep (1990) 2.20

The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. AIDS (1990) 1.76

Impact of the 1987 revision of the case definition of acquired immune deficiency syndrome in the United States. J Acquir Immune Defic Syndr (1990) 1.75

Underreporting of AIDS cases in Canada: a record linkage study. CMAJ (1990) 1.39

Acquired immune deficiency syndrome in Canada: the first 5 years of surveillance. CMAJ (1988) 1.34

Laboratory diagnosis of the first cases of HIV-2 infection in Canada. CMAJ (1989) 1.08

Willingness to participate in a national seroprevalence study of HIV infection. AIDS (1989) 1.01

HIV infections and AIDS in the 1990s. Annu Rev Public Health (1990) 1.00

Projecting the incidence of AIDS. JAMA (1990) 0.93

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med (1999) 6.13

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS (1989) 3.19

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I). Am J Hum Genet (1990) 3.10

Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res Hum Retroviruses (1996) 2.75

Patterns of sexual behavior and condom use in a cohort of homosexual men. Am J Public Health (1988) 2.57

Strategies for consulting with the community: the cases of four large-scale genetic databases. Sci Eng Ethics (2004) 2.47

A new probe for the diagnosis of myotonic muscular dystrophy. Science (1987) 2.35

Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr (1975) 2.25

The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J (1985) 2.11

Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction. J Clin Microbiol (1991) 2.05

The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men. CMAJ (1986) 2.01

On the application of knowledge to the patient with genetic disease. Prog Med Genet (1973) 1.84

Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr (1992) 1.78

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial. AIDS (1989) 1.78

Risk factors in pediatric AIDS. Can Med Assoc J (1985) 1.77

Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol (1994) 1.68

Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. J Adolesc Health (1999) 1.66

Genetics and Medicine: an evolving relationship. Science (1978) 1.65

Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63

Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol (1997) 1.60

The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Can Med Assoc J (1985) 1.59

Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group. J Clin Microbiol (1999) 1.58

Association of HTLV-III antibodies and cellular immune status of hemophiliacs. N Engl J Med (1984) 1.51

Transplacental transmission of HTLV-III virus. N Engl J Med (1985) 1.47

A randomised controlled trial of absorbable versus non-absorbable sutures for skin closure after open carpal tunnel release. J Hand Surg Eur Vol (2011) 1.46

Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture. J Cell Biol (1983) 1.45

Modification of a screening program for neonatal hypothyroidism. J Pediatr (1978) 1.44

Neonatal hypertyrosinemia and evidence for deficiency of ascorbic acid in Arctic and subarctic peoples. Can Med Assoc J (1975) 1.42

A simple technique for correction of mucosal irregularities of the lip. Plast Reconstr Surg (1998) 1.40

Novel PKU mutation on haplotype 2 in French-Canadians. Am J Hum Genet (1989) 1.40

Drug reinforcement studied by the use of place conditioning in rat. Brain Res (1982) 1.39

Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT Trial. AIDS (1993) 1.36

The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Can Med Assoc J (1985) 1.31

Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol (1995) 1.30

Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol (2001) 1.29

Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus (1999) 1.29

Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet (1990) 1.28

Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta (1982) 1.28

HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health (1994) 1.27

Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. Mem Inst Oswaldo Cruz (1997) 1.26

Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol (2003) 1.25

DNA sampling and informed consent. CMAJ (1989) 1.24

Thyroid function in neonatal hypothyroidism. J Pediatr (1976) 1.24

Immunocytochemical localization of secretory proteins in bovine pancreatic exocrine cells. J Cell Biol (1977) 1.21

[Thyroxine (T4) determination by radioimmunological method in dried blood eluate: new diagnostic method of neonatal hypothyroidism?]. Union Med Can (1973) 1.21

Aetiology and management of hypertrophic scars and keloids. Ann R Coll Surg Engl (1996) 1.20

Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid. Prenat Diagn (1982) 1.16

Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med (1983) 1.15

Hereditary tyrosinemia in a French Canadian isolate. Am J Hum Genet (1969) 1.15

TSH measurements from blood spots on filter paper: a confirmatory screening test for neonatal hypothyroidism. J Pediatr (1976) 1.14

Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. CMAJ (1998) 1.14

Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet (1999) 1.09

Sexuality in Montreal women living with HIV. AIDS Care (1997) 1.08

Adhesion of Helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect Immun (1996) 1.08

Antiretroviral treatment in 1998. Lancet (1998) 1.07

The role of chlamydiae in genitourinary disease. J Urol (1981) 1.06

Hereditary tyrosinemia in the province of Quebec: prevalence at birth and geographic distribution. Clin Genet (1974) 1.05

Thymic epithelium in AIDS. An immunohistologic study. Am J Pathol (1986) 1.05

Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol (2001) 1.05

HIV-1 infection among incarcerated men--Quebec. Can Dis Wkly Rep (1991) 1.05

Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia. J Immunol (1977) 1.04

Giant-cell pneumonia caused by parainfluenza virus. J Pediatr (1979) 1.04

HIV-1 infection in a medium security prison for women--Quebec. Can Dis Wkly Rep (1989) 1.04

Purification of mRNA coding for the enzyme deficient in hereditary tyrosinemia, fumarylacetoacetate hydrolase. Biochem Cell Biol (1986) 1.04

A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia. Clin Chim Acta (1974) 1.03

Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.01

Localization of secretory IgA, secretory component, and alpha chain in the mammary gland of lactating rabbits by immunoelectron microscopy. Ann N Y Acad Sci (1975) 1.01

HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs. Cell Mol Biol (Noisy-le-grand) (1995) 1.01

Genetic aspects of tyrosinemia in the Chicoutimi region. Can Med Assoc J (1967) 1.01

Tight linkage of creatine kinase (CKMM) to myotonic dystrophy on chromosome 19. Neurology (1990) 1.00

The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. Am J Hum Genet (1987) 1.00

Surgery in the treatment of varicose veins. Ir Med J (1989) 0.98

Is it possible to predict limb viability in complex Gustilo IIIB and IIIC tibial fractures? A comparison of two predictive indices. Injury (1998) 0.98

Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group. Int J Tuberc Lung Dis (1999) 0.97

Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol (2000) 0.96

The validity of the distinction between bulimia with and without anorexia nervosa. Am J Psychiatry (1985) 0.95

Improved detection of HIV-1 envelope sequences using optimized PCR and inosine-substituted primers. Mol Cell Probes (1991) 0.94

Subacute sclerosing panencephalitis. Elevated Epstein-Barr virus antibody titers and failure of amantadine therapy. J Neurol Sci (1974) 0.94

Thyroid antigen-antibody nephritis. Clin Immunol Immunopathol (1976) 0.94

Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res (1982) 0.93

[Demographic reproduction and genetic transmission in the north-east of the province of Quebec (18th-20th centuries)]. Eur J Popul (1988) 0.92

Endothelial cell heterogeneity in the normal human liver acinus: in situ immunohistochemical demonstration. Liver (1994) 0.92

Calcium alginate dressings promote healing of split skin graft donor sites. Acta Chir Plast (1997) 0.91

Epidemiology of HIV infection. Can J Public Health (1989) 0.91

Unusual prevalence of antibodies to Epstein-Barr virus early antigen in ataxia telangiectasia. Lancet (1977) 0.91

Pathogenicity of HIV in lymphatic organs of patients with AIDS. J Pathol (1987) 0.91

Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989-1993. Int J Epidemiol (1998) 0.91

5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro. Antimicrob Agents Chemother (1990) 0.90

Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr (1982) 0.90

Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med (1984) 0.90

A study of suicide and attempted suicide by self-immolation in an Irish psychiatric population: an increasing problem. Burns (1998) 0.90

The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme. Int J STD AIDS (1998) 0.90

Construction of single-chain antibodies that bind an overlapping epitope of HIV-1 Nef. FEBS Lett (1998) 0.89

Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.89

Development of a software package for trend detection in temporal series: Application to water and industrial effluent quality data for the St. Lawrence River. Environ Monit Assess (1989) 0.89

Attempts to quantitate immunocytochemistry at the electron microscope level. Histochem J (1980) 0.88

Lack of transmission of HIV through human bites and scratches. J Acquir Immune Defic Syndr (1988) 0.88

The effect of zidovudine on platelet count in HIV-infected individuals. J Acquir Immune Defic Syndr (1990) 0.88